Peripheral vascular disease

Coronary disease

Arterial Patency in Femoropopliteal Disease with Drug-Eluting Balloons

Follow-up of drug-coated balloon angioplasty in femoropopliteal disease in a real-world population. Using drug-releasing devices has decreased the...

solaci - 22 February, 2023

Learn More

Aorta

Uncomplicated Type B Aortic Dissection

Mortality Assessment, Interventions and Hospitalization in Patients with Uncomplicated Type B Aortic Dissection with TEVAR. Over 60% of...

solaci - 8 February, 2023

Learn More

Femoropopliteal

Stent Revascularization in Femoropopliteal Disease: An Analysis of Clustered Randomized Trials

A study compared pooled data of claudication and critical ischemia patients treated with stenting vs. by-pass surgery...

solaci - 7 February, 2023

Learn More

Femoral

What Is the Best Strategy for Moderately Complex Femoropopliteal Lesions?

At present, PCI is the preferred treatment for femoropopliteal lesions and drug coated balloons (DCB) have shown...

solaci - 31 January, 2023

Learn More

Coronary disease

IN.PACT Study | Should We Start Using DCBs More Frequently in Cases of Femoropopliteal Disease?

With the new devices (drug-eluting balloons , drug-eluting stents , and atherotomes) percutaneous treatment is becoming the...

solaci - 30 January, 2023

Learn More

Aorta

Intervention in Patients with Takayasu Arteritis: Rescue Therapy or an Alternative Complementary to Immunosuppressive Therapy?

Takayasu arteritis (TAK) is an uncommon granulomatous large-vessel vasculitis that affects the aorta and its primary branches. The...

solaci - 18 January, 2023

Learn More

Acute coronary syndromes

Is There Any Difference in Clinical Outcomes Between Transient and Persistent Acute Kidney Injury in ACS Patients after Invasive Treatment?

Acute kidney injury (AKI) following acute coronary syndrome (ACS) is associated with prolonged hospital stay and worse...

solaci - 5 January, 2023

Learn More

Other

Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

Pulmonary vessels are densely innervated by sympathetic, parasympathetic, and sensitive fibers. According to the World Health Organization (WHO)...

solaci - 14 December, 2022

Learn More

Arterial Patency in Femoropopliteal Disease with Drug-Eluting Balloons

Uncomplicated Type B Aortic Dissection

Stent Revascularization in Femoropopliteal Disease: An Analysis of Clustered Randomized Trials

What Is the Best Strategy for Moderately Complex Femoropopliteal Lesions?

IN.PACT Study | Should We Start Using DCBs More Frequently in Cases of Femoropopliteal Disease?

Intervention in Patients with Takayasu Arteritis: Rescue Therapy or an Alternative Complementary to Immunosuppressive Therapy?

Is There Any Difference in Clinical Outcomes Between Transient and Persistent Acute Kidney Injury in ACS Patients after Invasive Treatment?

Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

Last News

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Institutional News

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Watch our event on Evidence and Controversies of Renal Denervation in 2025

Access